PODD 2025 – Partnership Opportunities in Drug Delivery
27.-28. October 2025
Boston, US
https://poddconference.com/
News and Events
Subscribe to our press distribution list to receive the latest news about AMW.
Upcoming
Events
CPHI 2025
October 28-30, 2025
Frankfurt, Germany
https://www.cphi.com/europe/en/home.html
BIO-Europe 2025
November 3-5, 2025
Vienna, Austria
https://informaconnect.com/bioeurope/
Past
Events
Archive
Pharmapack
January 24-25, 2024 Paris, France https://www.pharmapackeurope.com/
read morePharmasynergy
February 08-09, 2024
London, UK
euroPLX84
February 26-27, 2024 Lisbon, Portugal
read moreBIO-Europe Spring
March 18-20, 2024
Barcelona, Spain
https://informaconnect.com/bioeurope-spring/
4th Wet AMD & Diabetic Eye Disease Drug Development
March 19-21, 2024
Boston, MA
https://wet-amd-drug-development.com/
BIO International Convention
June 03-06, 2024
San Diego, California
https://www.bio.org/events/bio-international-convention
CPHI South East Asia
July 10-12, 2024 Bangkok, Thailand https://www.cphi.com/sea/en/home.html
read moreCPHI 2024
October 08-10, 2024 Milan, Italy https://www.cphi.com/europe/en/home.html
read morePODD – Partnership Opportunities in Drug Delivery
October 28-29, 2024 Boston, USA https://poddconference.com
read moreBIO-Europe
November 04-06, 2024 Stockholm, Sweden https://informaconnect.com/bioeurope/
read morePharmaSynergyRx 2025
February 27-28, 2025
London, UK
https://pharma-synergy-conference.com/pharmasynergy-2025/
BIO-Europe Spring
March 17-19, 2025
Milan, Italy
https://informaconnect.com/bioeurope-spring/
DCAT Week 2025
March 17-20, 2025
New York City, USA
https://dcatweek.org/
AT Uro Congress
May 22-24, 2025
Vienna, Austria
EuroPLX
June 2-3, 2025
Lisbon, Portugal
CPHI South East Asia 2025
July 16-18, 2025
Kuala Lumpur, Malaysia
https://www.cphi.com/sea/en/home.html
Latest
News
AMW Strengthens Executive Leadership Team by Appointing Wolfram E. Scholl as Chief Operating Officer
Warngau, Germany, September 2, 2025 AMW GmbH, a specialty pharmaceutical company focused on biodegradable controlled-release drug delivery systems, today announced the appointment of Wolfram E. Scholl as Chief Operating Officer (COO) as of September 1, 2025. As long-standing expert and consultant in supply chain management, he is responsible for production, quality, supply chain, engineering and […]
read moreAMW Secures Successful Long-term Growth Financing from Raiffeisenlandesbank Oberösterreich
Warngau, Germany, July 24, 2025 AMW GmbH, a specialty pharmaceutical company focused on biodegradable controlled-release drug delivery systems, today announced the closing of a significant financing agreement. This long-term and attractive financing from Raiffeisenlandesbank Oberösterreich allowed the Company to optimize its financing structure and to gain access to an additional line of credit. “With another […]
read moreAMW and AdhexPharma Successfully Complete Strategic Transfer of Transdermal Delivery Systems
Warngau, Germany, Chenôve, France, May 27, 2025 AMW GmbH, a specialty pharmaceutical company focused on biodegradable controlled-release drug delivery systems, and AdhexPharma SAS, an independent pharmaceutical company specializing in the development and manufacturing of patches and oral films, today announced the successful completion of the transfer of transdermal delivery systems (TDS) under the companies’ strategic […]
read moreAMW Reports Another Record Result for the 2024 Financial Year
Warngau, Germany, May 13, 2025 AMW GmbH, a specialty pharmaceutical company focused on biodegradable controlled-release drug delivery systems, today reported financial results for the year ended December 31, 2024. AMW posted another consolidated record revenue for 2024 of EUR 38.2 million, an increase of 30% compared to the previous year (2023: EUR 29.4 million). The […]
read moreAMW Pioneers Use of Artificial Intelligence in Formulation Development
Warngau, February 25, 2025 AMW GmbH, a specialty pharmaceutical company focused on biodegradable controlled-release drug delivery systems, today announced the launch of a research and development project to optimize formulation development using artificial intelligence (AI). The working group of Prof. Dr. Olivia Merkel, Chair of Drug Delivery at the Department of Pharmacy at Ludwig-Maximilians-Universität (LMU) […]
read more